Citation: | SUN Le-shui, GE Xia. Expression and significance of eIF4E and CyclinD1 in endometrial hyperplasia and endometrial carcinoma[J]. Journal of Bengbu Medical University, 2013, 37(3): 258-262. |
[1] |
[2] Shantz LM, Pegg AL;. Over production of omithine decarboxylasecaused by relief of translational repression is associated withneoplastic transformation[J].Cancer Res,1994,54 (9):2313-2316.
|
[1] |
Altucci L, Arap W, Schaver IE et al. Cyclins and cancer: cyclinDand CDK inhibitors come to age[J].Oncogene, 1996, 12(10):2315.
|
[2] |
[3] De Benedetti A, Harris AL. eIF4E expression in tumors: itspossible rolein progression of malignancies[J].Int,J Biochem CellBiol,1999,31 (1):59-72.
|
[3] |
[4] De BenedettiA, Graff JR. eIF4E expression and its role inmalignancies and metastases.Oncogene, 2004, 23(18):3189-3199.
|
[4] |
[5] Rosenwald IB.The role of translation in neoplastic transformationfrom a pathologist's point of view[J].Oncogene,2004,23 (18):3230-3247.
|
[5] |
[6] Nathan CA, Leskov IL, Lin M, et al. COX2 expression in dysplasiaof the head and neck:correlation with eIF4E[J].Cancer,2001,92(7):1888-1895.
|
[6] |
[7] Berkel HJ, Turbat Herrera EA, Shi R, et al. Expression of thetranslation initiation factor eIF4E in the poly-cancer sequence inthe colon[J].Cancer Epidemiol Biomarkers Prev, 2001,10 (6):663-666.
|
[7] |
[8] Gu X,,Jones L, Lowery Norberg M, et al. Expression of eukaryoticinitiation factor 4E in astrocvtic tumors[J].Appl lmmunohistochemMol Morphol, 2005,13 (2):178-183.
|
[8] |
[9] Chen CN, Hsieh FJ, Cheng YM, et al. Expression of eukaryoticinitiation factor 4E in gastric adenocarcinoma and its associationwith clinical outcome[J].J Surg Onco1,2004,86 (1):22-27.
|
[9] |
[10] Zhou S, Wang GP, Liu C, et al. Eukaryotic initiation factor 4E(eIF4E) and angiogenesis: prognostic markers for breast cancer[J].BMC Cancer,2006,6:231.
|
[10] |
[11] Zhou,JX,Niehans GA,SharA,et al. Mechanisms of Gl checkpointlossin rescted early stage non-small cell lung cancer[J].Lung Cancer,2001,32(1):27-38.
|
[11] |
[12] Moghaddam SJ, Haghighi EN, Samiee S, et al. Immunohistochemicalanalysis of p53, cyclinDl, RB1, c-fos and N-ras gene expression inhepatocellular carcinoma in Iran[J].World,J Gastro enterol, 2007,13 (4):588-593.
|
[12] |
[13] Rose SL, Buller RL,. The role of p53 mutation in BRCA1- associated ovarian cancer[J].Minerva Ginecol, 2002, 54 (3): 201-209.
|
[13] |
[14] Wang C,Li Z,Fu M,et al. Signal transduction mediated by cyclinDl: from genes to cell proliferation: a molecular target with therapeutic potential[J].Cancer Treat Res, 2004,119:217-237.
|
[14] |
[15] Ivan Topisirovic ML, Guzman MJ, McConnell JD, et al. Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis[J].Mol Cell Bio1,2003,23 (24):8992-9002.
|
[15] |
[16] T'suda H, Yamamoto K, Inoue T, et al. The role of p16-cyclind/ CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma[J].Br J Cancer, 2000, 82 (3):675-682.
|